Janssen HL - Search Results

1

Sharma S, Carballo M, Feld JJ, Janssen HL. Sharma S, et al. Among authors: janssen hl. J Hepatol. 2015 Aug;63(2):515-22. doi: 10.1016/j.jhep.2015.04.026. Epub 2015 May 8. J Hepatol. 2015. PMID: 25962882 Free article. Review.

2

Suicide associated with alfa-interferon therapy for chronic viral hepatitis.

Janssen HL, Brouwer JT, van der Mast RC, Schalm SW. Janssen HL, et al. J Hepatol. 1994 Aug;21(2):241-3. doi: 10.1016/s0168-8278(05)80402-7. J Hepatol. 1994. PMID: 7989716

3

Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).

Janssen HL, Gerken G, Carreño V, Marcellin P, Naoumov NV, Craxi A, Ring-Larsen H, Kitis G, van Hattum J, de Vries RA, Michielsen PP, ten Kate FJ, Hop WC, Heijtink RA, Honkoop P, Schalm SW. Janssen HL, et al. Hepatology. 1999 Jul;30(1):238-43. doi: 10.1002/hep.510300113. Hepatology. 1999. PMID: 10385662 Clinical Trial.

4

Combination and newer therapies for chronic hepatitis B.

Schalm SW, De Man RA, Janssen HL. Schalm SW, et al. Among authors: janssen hl. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S338-41. doi: 10.1046/j.1440-1746.17.s3.24.x. J Gastroenterol Hepatol. 2002. PMID: 12472960

5

Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression.

Janssen HL, Higuchi H, Abdulkarim A, Gores GJ. Janssen HL, et al. J Hepatol. 2003 Sep;39(3):414-20. doi: 10.1016/s0168-8278(03)00265-4. J Hepatol. 2003. PMID: 12927928

6

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.

van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL. van Zonneveld M, et al. Among authors: janssen hl. Hepatology. 2004 Mar;39(3):804-10. doi: 10.1002/hep.20128. Hepatology. 2004. PMID: 14999700

7

Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome.

Janssen HL, van Zonneveld M, van Nunen AB, Niesters HG, Schalm SW, de Man RA. Janssen HL, et al. Eur J Gastroenterol Hepatol. 2004 Aug;16(8):801-7. doi: 10.1097/01.meg.0000108362.41221.57. Eur J Gastroenterol Hepatol. 2004. PMID: 15256984

8

Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

van der Molen RG, Sprengers D, Binda RS, de Jong EC, Niesters HG, Kusters JG, Kwekkeboom J, Janssen HL. van der Molen RG, et al. Among authors: janssen hl. Hepatology. 2004 Sep;40(3):738-46. doi: 10.1002/hep.20366. Hepatology. 2004. PMID: 15349914

9

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, Janssen HL. Stoop JN, et al. Among authors: janssen hl. Hepatology. 2005 Apr;41(4):771-8. doi: 10.1002/hep.20649. Hepatology. 2005. PMID: 15791617

10

Intrahepatic CD8+ T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection.

Tang TJ, Kwekkeboom J, Mancham S, Binda RS, de Man RA, Schalm SW, Kusters JG, Janssen HL. Tang TJ, et al. Among authors: janssen hl. J Hepatol. 2005 Jul;43(1):45-52. doi: 10.1016/j.jhep.2005.01.038. Epub 2005 Apr 25. J Hepatol. 2005. PMID: 15893402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

615 results

Search Page